Literature DB >> 20791446

New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine.

G S Stokes, J T Potts, M Lotz, F C Bartter.   

Abstract

Entities:  

Year:  1968        PMID: 20791446      PMCID: PMC1985030          DOI: 10.1136/bmj.1.5587.284

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  20 in total

1.  TREATMENT OF CYSTINURIA.

Authors:  C E DENT; M FRIEDMAN; H GREEN; L C WATSON
Journal:  Br Med J       Date:  1965-02-13

2.  The determination in urine of some metabolites of tryptophankynurenine, anthranilic acid and 3-hydroxyanthranilic acid- and reference to the presence of o-aminophenol in urine.

Authors:  S L TOMPSETT
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  L-penicillamine and rat liver transaminase activity.

Authors:  V DU VIGNEAUD; E J KUCHINSKAS; A HORVATH
Journal:  Arch Biochem Biophys       Date:  1957-07       Impact factor: 4.013

4.  The use of oral choline in cystinuria.

Authors:  V COXON; F O KOLB
Journal:  Metabolism       Date:  1954-05       Impact factor: 8.694

5.  Studies on copper metabolism I. A method for the determination of copper in whole blood, red blood cells, and plasma.

Authors:  C J GUBLER; M E LAHEY; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

6.  CYSTINURIA AND CYSTINE LITHIASIS.

Authors:  F S Patch
Journal:  Can Med Assoc J       Date:  1934-09       Impact factor: 8.262

7.  Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.

Authors:  E D Harris; A Sjoerdsma
Journal:  Lancet       Date:  1966-11-05       Impact factor: 79.321

8.  Effect of penicillamine on serum iron.

Authors:  J M Walshe; V Patston
Journal:  Arch Dis Child       Date:  1965-12       Impact factor: 3.791

9.  Stone dissolution with D-penicillamine in cystinuria.

Authors:  M Lotz; F C Bartter
Journal:  Br Med J       Date:  1965-12-11

10.  Dietary methionine and its influence on cystine excretion in cystinuric patients.

Authors:  H H Zinneman; J E Jones
Journal:  Metabolism       Date:  1966-10       Impact factor: 8.694

View more
  8 in total

1.  Characterization of an S-nitroso-N-acetylpenicillamine-based nitric oxide releasing polymer from a translational perspective.

Authors:  Marcus J Goudie; Elizabeth J Brisbois; Jitendra Pant; Alex Thompson; Joseph A Potkay; Hitesh Handa
Journal:  Int J Polym Mater       Date:  2016-06-15       Impact factor: 2.604

2.  Biotemplated Synthesis and Characterization of Mesoporous Nitric Oxide-Releasing Diatomaceous Earth Silica Particles.

Authors:  Bryan M Grommersch; Jitendra Pant; Sean P Hopkins; Marcus J Goudie; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2018-01-11       Impact factor: 9.229

3.  Cystine stones treated by surgery and D-penicillamine.

Authors:  A G Hutchison
Journal:  Proc R Soc Med       Date:  1968-11

4.  Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.

Authors:  G Virella; M F Lopes-Virella
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

5.  Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release.

Authors:  Sean P Hopkins; Jitendra Pant; Marcus J Goudie; Chad Schmiedt; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2018-08-01       Impact factor: 9.229

Review 6.  Cystinuria and its treatment: 25 years experience at St. Bartholomew's Hospital.

Authors:  A D Stephens
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Dissolution of bilateral staghorn cystine renal calculi.

Authors:  G R Van Dugteren; J Wiggelinkhuizen
Journal:  Arch Dis Child       Date:  1979-10       Impact factor: 3.791

8.  Environmental contaminants and intestinal function.

Authors:  J G Banwell
Journal:  Environ Health Perspect       Date:  1979-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.